Barclays PLC Global Blood Therapeutics, Inc. Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022
SELL
$32.4 - $68.18 $14.9 Million - $31.4 Million
-461,042 Reduced 77.95%
130,434 $8.88 Million
Q2 2022

Aug 12, 2022
BUY
$22.3 - $37.39 $11.8 Million - $19.8 Million
530,438 Added 869.03%
591,476 $18.9 Million
Q1 2022

May 16, 2022
SELL
$25.68 - $35.59 $363,372 - $503,598
-14,150 Reduced 18.82%
61,038 $2.11 Million
Q4 2021

Feb 14, 2022
SELL
$24.9 - $40.26 $137,348 - $222,074
-5,516 Reduced 6.83%
75,188 $2.2 Million
Q3 2021

Nov 09, 2021
SELL
$25.48 - $37.34 $409,387 - $599,941
-16,067 Reduced 16.6%
80,704 $2.06 Million
Q2 2021

Aug 13, 2021
BUY
$32.46 - $43.42 $672,636 - $899,749
20,722 Added 27.25%
96,771 $3.39 Million
Q1 2021

May 13, 2021
SELL
$38.94 - $50.85 $1.35 Million - $1.76 Million
-34,692 Reduced 31.33%
76,049 $3.1 Million
Q4 2020

Feb 11, 2021
BUY
$37.65 - $63.77 $1.44 Million - $2.43 Million
38,144 Added 52.54%
110,741 $4.8 Million
Q3 2020

Nov 12, 2020
BUY
$52.76 - $74.49 $3.27 Million - $4.61 Million
61,898 Added 578.54%
72,597 $4 Million
Q2 2020

Aug 12, 2020
SELL
$48.73 - $81.82 $4.14 Million - $6.96 Million
-85,008 Reduced 88.82%
10,699 $675,000
Q1 2020

May 13, 2020
SELL
$41.72 - $87.2 $1.96 Million - $4.09 Million
-46,892 Reduced 32.88%
95,707 $4.89 Million
Q4 2019

Feb 10, 2020
BUY
$45.7 - $81.86 $4.99 Million - $8.94 Million
109,179 Added 326.69%
142,599 $11.3 Million
Q3 2019

Nov 14, 2019
SELL
$45.35 - $57.91 $1.01 Million - $1.29 Million
-22,258 Reduced 39.98%
33,420 $1.62 Million
Q2 2019

Aug 14, 2019
BUY
$52.6 - $63.29 $2 Million - $2.41 Million
38,015 Added 215.22%
55,678 $2.93 Million
Q1 2019

May 15, 2019
SELL
$39.99 - $53.48 $62,944 - $84,177
-1,574 Reduced 8.18%
17,663 $935,000
Q4 2018

Feb 14, 2019
SELL
$31.54 - $46.67 $687,351 - $1.02 Million
-21,793 Reduced 53.11%
19,237 $789,000
Q3 2018

Nov 14, 2018
BUY
$38.0 - $51.1 $1.36 Million - $1.83 Million
35,736 Added 675.03%
41,030 $1.56 Million
Q2 2018

Aug 14, 2018
SELL
$38.7 - $50.15 $962,585 - $1.25 Million
-24,873 Reduced 82.45%
5,294 $239,000
Q1 2018

May 15, 2018
SELL
$39.6 - $65.9 $2.44 Million - $4.06 Million
-61,626 Reduced 67.14%
30,167 $1.46 Million
Q4 2017

Feb 14, 2018
SELL
$29.7 - $45.7 $15,176 - $23,352
-511 Reduced 0.55%
91,793 $3.61 Million
Q3 2017

Nov 14, 2017
BUY
$25.1 - $31.05 $2.32 Million - $2.87 Million
92,304
92,304 $2.87 Million

Others Institutions Holding GBT

# of Institutions
8
Shares Held
288K
Call Options Held
0
Put Options Held
0
View Full List

About Global Blood Therapeutics, Inc.

GBT Quotes by TradingView
  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email